Approximately 85 to 95% of early-stage biotechnology companies fail. They struggle with the unpredictable nature of science, the high cost of bringing products to market, complex regulations, and the need for specialized facilities.
We reduce new venture risk by lowering the overhead costs of R&D and product launch. Access to over $1 million of core scientific equipment, invaluable mentorship, and investor + legal introductions are here for you.
Your success is our success. Established in 1990, our facility is one of the most experienced bio-business incubators in the nation. In fact, 85% of our companies were still operating five years after graduating from our program … MORE